Ledger.Open graph →
SEC Form D · filed August 14, 2014

Juno Therapeutics, Inc

Offering
$133.7M
Sold
$85.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Paul A. Wyckoff · KIRKLAND, WAExecChris A. Mccormack · KIRKLAND, WADirector · PromoterScott A. Laitinen · Toronto, Ontario, CanadaDirector · PromoterStephan A. Weitz · KIRKLAND, WAExecPatricio A. Stocker · Toronto, Ontario, CanadaDirectorGordon A. Gardiner · KIRKLAND, WAExecMark J. Knepper · Rancho Santa Fe, CADirectorCarlos Manuel A. Uribe · Toronto, Ontario, CanadaExecErnest T. Cummins · Albuquerque, NMDirector · PromoterSteven D. Mckean · KIRKLAND, WAExec · DirectorMatthew D. Campbell · Rancho Santa Fe, CAExec · Director · PromoterChristopher A. Hansen · Toronto, Ontario, CanadaDirectorJulie A. Barbo · KIRKLAND, WADirectorPaul M. Duncan · Arvada, COExec · Director · PromoterSimon A. Langelier · Toronto, Ontario, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗